Morgan Stanley on Rocket Pharmaceuticals (RCKT): approval marks 'positive readthrough to broader pipeline'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| (NASDAQ: RCKT) | Delayed: 2.44 -0.1 (3.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.54 | 52 Week High | $ | |||
| Open | $2.50 | 52 Week Low | $ | |||
| Day High | $2.57 | P/E | N/A | |||
| Day Low | $2.37 | EPS | $ | |||
| Volume | 1,535,035 | |||||
